{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:57:50Z","timestamp":1785499070694,"version":"3.56.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA247441"],"award-info":[{"award-number":["R01CA247441"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>T cell distribution within tumors (\u201ctumor hotness\u201d) critically determines the success of immunotherapy. However, despite numerous strategies to enhance intratumoral T cell accumulation \u2013 such as multi-target CAR-Ts and combinatorial approaches \u2013 limited mechanistic understanding of T cell\u2013microenvironment interactions has constrained progress. To address this, we developed a mechanistic physiological model of the 3D tumor microenvironment (TME) to evaluate CAR-T performance under environmental fluctuations and across different infusion strategies. The model integrates key vascular (rolling, firm adhesion, endothelial suppression) and interstitial (ECM density, metabolic competition, chemokine sensitivity) barriers. Our simulations reveal that collagen density and metabolic competition are dominant factors in CAR-T efficacy. Enhancing vascular rolling and firm adhesion improves infiltration but remains limited by collagen and metabolism. Endothelial suppression markedly reduces tumor hotness, while its alleviation enhances response. Systemic infusion yields higher tumor hotness than intratumoral delivery, but combined routes or reduced collagen density restore efficacy, even in dense tumors. This mechanistic framework enables rational optimization of CAR-T strategies.<\/jats:p>","DOI":"10.1038\/s41598-026-50412-6","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T13:05:05Z","timestamp":1779541505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A hybrid multiscale model for predicting CAR-T therapy outcomes in solid tumors"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammad R.","family":"Nikmaneshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance L.","family":"Munn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"50412_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","volume":"30","author":"CE Brown","year":"2024","unstructured":"Brown, C. E. et al. Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. Nat. Med. 30, 1001\u20131012 (2024).","journal-title":"Nat. Med."},{"key":"50412_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B., Zhang, B., Li, B., Wu, H. & Jiang, M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal. Transduct. Target. therapy. 9, 274 (2024).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"50412_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail, M., Jiang, C. H. & Li, N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal. Transduct. Target. Therapy. 10, 227 (2025).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"50412_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0006-3495(96)79248-2","volume":"71","author":"LL Munn","year":"1996","unstructured":"Munn, L. L., Melder, R. J. & Jain, R. K. Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. Biophys. J. 71, 466\u2013478 (1996).","journal-title":"Biophys. J."},{"key":"50412_CR5","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0006-3495(95)80087-1","volume":"69","author":"R Melder","year":"1995","unstructured":"Melder, R., Munn, L., Yamada, S., Ohkubo, C. & Jain, R. Selectin-and integrin-mediated T-lymphocyte rolling and arrest on TNF-alpha-activated endothelium: augmentation by erythrocytes. Biophys. J. 69, 2131\u20132138 (1995).","journal-title":"Biophys. J."},{"key":"50412_CR6","doi-asserted-by":"publisher","first-page":"635263","DOI":"10.3389\/fcell.2021.635263","volume":"9","author":"AB Schwartz","year":"2021","unstructured":"Schwartz, A. B. et al. Elucidating the biomechanics of leukocyte transendothelial migration by quantitative imaging. Front. cell. Dev. biology. 9, 635263 (2021).","journal-title":"Front. cell. Dev. biology"},{"key":"50412_CR7","doi-asserted-by":"crossref","unstructured":"Carlos, T. M. & Harlan, J. M. Leukocyte-endothelial adhesion molecules. Blood. 84, 7522621 (1994).","DOI":"10.1182\/blood.V84.7.2068.2068"},{"key":"50412_CR8","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/S0006-3495(03)74695-5","volume":"85","author":"AO Eniola","year":"2003","unstructured":"Eniola, A. O., Willcox, P. J. & Hammer, D. A. Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys. J. 85, 2720\u20132731 (2003).","journal-title":"Biophys. J."},{"key":"50412_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm.3541","volume":"20","author":"GT Motz","year":"2014","unstructured":"Motz, G. T. et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat. Med. 20, 607\u2013615 (2014).","journal-title":"Nat. Med."},{"key":"50412_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells\u2014partnering up with the immune system? Nat. Rev. Immunol. 22, 576\u2013588 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"50412_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang, J. et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 14, 586 (2023).","journal-title":"Cell Death Dis."},{"key":"50412_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massagu\u00e9, J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"50412_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi, M. et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal. Transduct. Target. therapy. 9, 176 (2024).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"50412_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng, Z. et al. TGF-\u03b2 signaling in health, disease and therapeutics. Signal. Transduct. Target. therapy. 9, 61 (2024).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"50412_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie, Y., Tang, F., Wei, Y. & Wei X.-w. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J. Hematol. Oncol. 15, 61 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"50412_CR16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/nm0996-992","volume":"2","author":"R Melder","year":"1996","unstructured":"Melder, R. et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2, 992\u2013997 (1996).","journal-title":"Nat. Med."},{"issue":"8","key":"50412_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41565-025-01924-1","volume":"20","author":"Z Zhao","year":"2025","unstructured":"Zhao, Z. et al. A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer. Nat. Nanotechnol. 20 (8), 1131\u20131141 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"50412_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-021-00323-4","volume":"3","author":"B Leitinger","year":"2022","unstructured":"Leitinger, B. Pulling the strings of tumor collagen. Nat. Cancer. 3, 9\u201310 (2022).","journal-title":"Nat. Cancer"},{"key":"50412_CR19","doi-asserted-by":"publisher","first-page":"2304076","DOI":"10.1002\/advs.202304076","volume":"10","author":"MR Nikmaneshi","year":"2023","unstructured":"Nikmaneshi, M. R., Baish, J. W., Zhou, H., Padera, T. P. & Munn, L. L. Transport Barriers Influence the Activation of Anti-Tumor Immunity: A Systems Biology Analysis. Adv. Sci. 10, 2304076 (2023).","journal-title":"Adv. Sci."},{"key":"50412_CR20","doi-asserted-by":"publisher","first-page":"1378034","DOI":"10.3389\/fphar.2024.1378034","volume":"15","author":"K Mi","year":"2024","unstructured":"Mi, K. et al. A physiologically based pharmacokinetic\/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against Streptococcus suis. Front. Pharmacol. 15, 1378034 (2024).","journal-title":"Front. Pharmacol."},{"key":"50412_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10928-017-9559-4","volume":"45","author":"C Niederalt","year":"2018","unstructured":"Niederalt, C. et al. A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim. J. Pharmacokinet. Pharmacodyn. 45, 235\u2013257 (2018).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"50412_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10928-021-09772-x","volume":"48","author":"Z Li","year":"2021","unstructured":"Li, Z., Li, Y., Chang, H. P., Yu, X. & Shah, D. K. Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice. J. Pharmacokinet. Pharmacodyn. 48, 743\u2013762 (2021).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"50412_CR23","doi-asserted-by":"publisher","first-page":"e1013117","DOI":"10.1371\/journal.pcbi.1013117","volume":"21","author":"K Owens","year":"2025","unstructured":"Owens, K., Rahman, A. & Bozic, I. Spatiotemporal dynamics of tumor\u2013CAR T-cell interaction following local administration in solid cancers. PLoS Comput. Biol. 21, e1013117 (2025).","journal-title":"PLoS Comput. Biol."},{"key":"50412_CR24","first-page":"362","volume":"10","author":"AP Singh","year":"2021","unstructured":"Singh, A. P. et al. Bench-to\u2010bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic\u2010pharmacodynamic model: A case study with anti\u2010BCMA CAR\u2010T. CPT: Pharmacometrics Syst. Pharmacol. 10, 362\u2013376 (2021).","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"key":"50412_CR25","doi-asserted-by":"publisher","first-page":"e1009318","DOI":"10.1371\/journal.pcbi.1009318","volume":"17","author":"M Rodriguez Messan","year":"2021","unstructured":"Rodriguez Messan, M. et al. Mathematical model of a personalized neoantigen cancer vaccine and the human immune system. PLoS Comput. Biol. 17, e1009318 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"50412_CR26","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1038\/s41467-023-37933-8","volume":"14","author":"JH Creemers","year":"2023","unstructured":"Creemers, J. H. et al. In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nat. Commun. 14, 2348 (2023).","journal-title":"Nat. Commun."},{"key":"50412_CR27","doi-asserted-by":"publisher","first-page":"111437","DOI":"10.1016\/j.jtbi.2023.111437","volume":"563","author":"P Khalili","year":"2023","unstructured":"Khalili, P. & Vatankhah, R. Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer. J. Theor. Biol. 563, 111437 (2023).","journal-title":"J. Theor. Biol."},{"key":"50412_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.neo.7900209","volume":"4","author":"RJ Melder","year":"2002","unstructured":"Melder, R. J. et al. Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model. Neoplasia 4, 3\u20138 (2002).","journal-title":"Neoplasia"},{"key":"50412_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.neo.7900260","volume":"4","author":"SW Friedrich","year":"2002","unstructured":"Friedrich, S. W. et al. Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model. Neoplasia 4, 449\u2013463 (2002).","journal-title":"Neoplasia"},{"key":"50412_CR30","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1038\/s41598-022-13345-4","volume":"12","author":"FM Kashkooli","year":"2022","unstructured":"Kashkooli, F. M., Abazari, M. A., Soltani, M., Ghazani, M. A. & Rahmim, A. A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis. Sci. Rep. 12, 10062 (2022).","journal-title":"Sci. Rep."},{"key":"50412_CR31","doi-asserted-by":"publisher","first-page":"118965","DOI":"10.1016\/j.ces.2023.118965","volume":"280","author":"I Lampropoulos","year":"2023","unstructured":"Lampropoulos, I. & Kavousanakis, M. Application of combination chemotherapy in two dimensional tumor growth model with heterogeneous vasculature. Chem. Eng. Sci. 280, 118965 (2023).","journal-title":"Chem. Eng. Sci."},{"key":"50412_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10915-020-01326-6","volume":"85","author":"J Droniou","year":"2020","unstructured":"Droniou, J., Flegg, J. A. & Remesan, G. C. Numerical solution of a two dimensional tumour growth model with moving boundary. J. Sci. Comput. 85, 22 (2020).","journal-title":"J. Sci. Comput."},{"key":"50412_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41540-024-00439-0","volume":"10","author":"S Pasetto","year":"2024","unstructured":"Pasetto, S. et al. Calibrating tumor growth and invasion parameters with spectral spatial analysis of cancer biopsy tissues. npj Syst. Biology Appl. 10, 112 (2024).","journal-title":"npj Syst. Biology Appl."},{"key":"50412_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jtbi.2017.10.005","volume":"436","author":"H Cho","year":"2018","unstructured":"Cho, H. & Levy, D. Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth. J. Theor. Biol. 436, 120\u2013134 (2018).","journal-title":"J. Theor. Biol."},{"key":"50412_CR35","doi-asserted-by":"publisher","first-page":"104507","DOI":"10.1016\/j.compbiomed.2021.104507","volume":"134","author":"DA Goodin","year":"2021","unstructured":"Goodin, D. A. & Frieboes, H. B. Simulation of 3D centimeter-scale continuum tumor growth at sub-millimeter resolution via distributed computing. Comput. Biol. Med. 134, 104507 (2021).","journal-title":"Comput. Biol. Med."},{"key":"50412_CR36","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1158\/0008-5472.CAN-06-4102","volume":"67","author":"RK Jain","year":"2007","unstructured":"Jain, R. K., Tong, R. T. & Munn, L. L. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res. 67, 2729\u20132735 (2007).","journal-title":"Cancer Res."},{"key":"50412_CR37","doi-asserted-by":"publisher","first-page":"e1007243","DOI":"10.1371\/journal.pcbi.1007243","volume":"15","author":"K Chkhaidze","year":"2019","unstructured":"Chkhaidze, K. et al. Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data. PLoS Comput. Biol. 15, e1007243 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"50412_CR38","first-page":"1","volume":"2","author":"J Metzcar","year":"2019","unstructured":"Metzcar, J., Wang, Y., Heiland, R. & Macklin, P. A review of cell-based computational modeling in cancer biology. JCO Clin. cancer Inf. 2, 1\u201313 (2019).","journal-title":"JCO Clin. cancer Inf."},{"key":"50412_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fonc.2013.00087","volume":"3","author":"A Szab\u00f3","year":"2013","unstructured":"Szab\u00f3, A. & Merks, R. M. Cellular potts modeling of tumor growth, tumor invasion, and tumor evolution. Front. Oncol. 3, 87 (2013).","journal-title":"Front. Oncol."},{"key":"50412_CR40","doi-asserted-by":"publisher","first-page":"106481","DOI":"10.1016\/j.compbiomed.2022.106481","volume":"153","author":"CA Valentim","year":"2023","unstructured":"Valentim, C. A., Rabi, J. A. & David, S. A. Cellular-automaton model for tumor growth dynamics: Virtualization of different scenarios. Comput. Biol. Med. 153, 106481 (2023).","journal-title":"Comput. Biol. Med."},{"key":"50412_CR41","doi-asserted-by":"publisher","first-page":"065003","DOI":"10.1088\/1478-3975\/10\/6\/065003","volume":"10","author":"LL Munn","year":"2013","unstructured":"Munn, L. L. Dynamics of tissue topology during cancer invasion and metastasis. Phys. Biol. 10, 065003 (2013).","journal-title":"Phys. Biol."},{"key":"50412_CR42","doi-asserted-by":"publisher","first-page":"e7190","DOI":"10.1371\/journal.pone.0007190","volume":"4","author":"A Shirinifard","year":"2009","unstructured":"Shirinifard, A. et al. 3D multi-cell simulation of tumor growth and angiogenesis. PloS one. 4, e7190 (2009).","journal-title":"PloS one"},{"key":"50412_CR43","doi-asserted-by":"publisher","first-page":"e83962","DOI":"10.1371\/journal.pone.0083962","volume":"9","author":"L Tang","year":"2014","unstructured":"Tang, L. et al. Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation. PloS one. 9, e83962 (2014).","journal-title":"PloS one"},{"key":"50412_CR44","doi-asserted-by":"publisher","first-page":"e1009081","DOI":"10.1371\/journal.pcbi.1009081","volume":"17","author":"S Jafari Nivlouei","year":"2021","unstructured":"Jafari Nivlouei, S. et al. Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy. PLoS Comput. Biol. 17, e1009081 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"50412_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1752-0509-7-S2-S12","volume":"7","author":"F Li","year":"2013","unstructured":"Li, F. et al. A 3D multiscale model of cancer stem cell in tumor development. BMC Syst. Biol. 7, 12 (2013).","journal-title":"BMC Syst. Biol."},{"key":"50412_CR46","doi-asserted-by":"publisher","first-page":"20170320","DOI":"10.1098\/rsif.2017.0320","volume":"14","author":"C Gong","year":"2017","unstructured":"Gong, C. et al. A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition. J. Royal Soc. Interface. 14, 20170320 (2017).","journal-title":"J. Royal Soc. Interface"},{"key":"50412_CR47","doi-asserted-by":"crossref","unstructured":"Norton, K., Gong, C., Jamalian, S. & Popel, A. Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment. Processes. 7 10.3390\/pr7010037 (2019).","DOI":"10.3390\/pr7010037"},{"key":"50412_CR48","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/s41598-020-59658-0","volume":"10","author":"MR Nikmaneshi","year":"2020","unstructured":"Nikmaneshi, M. R., Firoozabadi, B., Mozafari, A. & Munn, L. L. A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth. Sci. Rep. 10, 3025 (2020).","journal-title":"Sci. Rep."},{"key":"50412_CR49","doi-asserted-by":"publisher","first-page":"e1011131","DOI":"10.1371\/journal.pcbi.1011131","volume":"19","author":"MR Nikmaneshi","year":"2023","unstructured":"Nikmaneshi, M. R., Jain, R. K. & Munn, L. L. Computational simulations of tumor growth and treatment response: benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization. PLoS Comput. Biol. 19, e1011131 (2023).","journal-title":"PLoS Comput. Biol."},{"key":"50412_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11538-024-01371-4","volume":"86","author":"LV Kunz","year":"2024","unstructured":"Kunz, L. V. et al. AMBER: A Modular Model for Tumor Growth, Vasculature and Radiation Response. Bull. Math. Biol. 86, 139 (2024).","journal-title":"Bull. Math. Biol."},{"key":"50412_CR51","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10237-022-01587-0","volume":"21","author":"MR Nikmaneshi","year":"2022","unstructured":"Nikmaneshi, M. R. & Firoozabadi, B. Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment. Biomech. Model. Mechanobiol. 21, 1233\u20131249 (2022).","journal-title":"Biomech. Model. Mechanobiol."},{"key":"50412_CR52","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1002\/bit.27863","volume":"118","author":"MR Nikmaneshi","year":"2021","unstructured":"Nikmaneshi, M. R., Firoozabadi, B. & Mozafari, A. Chemo-mechanistic multi\u2010scale model of a three\u2010dimensional tumor microenvironment to quantify the chemotherapy response of cancer. Biotechnol. Bioeng. 118, 3871\u20133887 (2021).","journal-title":"Biotechnol. Bioeng."},{"key":"50412_CR53","first-page":"115","volume":"3","author":"KA Rejniak","year":"2011","unstructured":"Rejniak, K. A. & Anderson, A. R. Hybrid models of tumor growth. Wiley Interdisciplinary Reviews: Syst. Biology Med. 3, 115\u2013125 (2011).","journal-title":"Wiley Interdisciplinary Reviews: Syst. Biology Med."},{"key":"50412_CR54","doi-asserted-by":"publisher","first-page":"105597","DOI":"10.1016\/j.ebiom.2025.105597","volume":"113","author":"A Murias-Closas","year":"2025","unstructured":"Murias-Closas, A., Prats, C., Calvo, G., L\u00f3pez-Codina, D. & Olesti, E. Computational modelling of CAR T-cell therapy: from cellular kinetics to patient-level predictions. EBioMedicine 113, 105597 (2025).","journal-title":"EBioMedicine"},{"key":"50412_CR55","doi-asserted-by":"publisher","first-page":"1581210","DOI":"10.3389\/fimmu.2025.1581210","volume":"16","author":"G Putignano","year":"2025","unstructured":"Putignano, G., Ruip\u00e9rez-Campillo, S., Yuan, Z., Millet, J. & Guerrero-Aspizua, S. Mathematical models and computational approaches in CAR-T therapeutics. Front. Immunol. 16, 1581210 (2025).","journal-title":"Front. Immunol."},{"key":"50412_CR56","doi-asserted-by":"publisher","first-page":"110427","DOI":"10.1016\/j.compbiomed.2025.110427","volume":"194","author":"S Bordel-Vozmediano","year":"2025","unstructured":"Bordel-Vozmediano, S., Sabir, S., Benito-Barca, L. & Weigelin, B. P\u00e9rez-Garc\u00eda, V. M. Geometric immunosuppression in CAR T-cell treatment: Insights from mathematical modeling. Comput. Biol. Med. 194, 110427 (2025).","journal-title":"Comput. Biol. Med."},{"key":"50412_CR57","doi-asserted-by":"publisher","first-page":"849363","DOI":"10.3389\/fmolb.2022.849363","volume":"9","author":"AN Prybutok","year":"2022","unstructured":"Prybutok, A. N., Yu, J. S., Leonard, J. N. & Bagheri, N. Mapping CAR T-cell design space using agent-based models. Front. Mol. Biosci. 9, 849363 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"50412_CR58","doi-asserted-by":"crossref","unstructured":"Xiao, Z. et al.  Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat. Commun. 14, 5110 (2023).","DOI":"10.1038\/s41467-023-40850-5"},{"key":"50412_CR59","doi-asserted-by":"publisher","first-page":"117194","DOI":"10.1016\/j.bcp.2025.117194","volume":"241","author":"X Kong","year":"2025","unstructured":"Kong, X. et al. Transforming the cold tumors to hot tumors: strategies for immune activation. Biochem. Pharmacol. 241, 117194 (2025).","journal-title":"Biochem. Pharmacol."},{"key":"50412_CR60","doi-asserted-by":"crossref","unstructured":"Ganjal\u0131khani-Hakemi, M., Demirel, Y., He, G. & Zeng, C. X. Immunologic tumor microenvironment modulators for turning \u201ccold\u201d tumors to \u201chot\u201d tumors. Front. Immunol. 15, 1425136 (2024).","DOI":"10.3389\/fimmu.2024.1425136"},{"key":"50412_CR61","doi-asserted-by":"publisher","first-page":"eaaz0868","DOI":"10.1126\/science.aaz0868","volume":"370","author":"HT Nia","year":"2020","unstructured":"Nia, H. T., Munn, L. L. & Jain, R. K. Physical traits of cancer. Science 370, eaaz0868 (2020).","journal-title":"Science"},{"key":"50412_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","volume":"68","author":"K Newick","year":"2017","unstructured":"Newick, K., O\u2019Brien, S., Moon, E. & Albelda, S. M. CAR T cell therapy for solid tumors. Annu. Rev. Med. 68, 139\u2013152 (2017).","journal-title":"Annu. Rev. Med."},{"key":"50412_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood cancer J. 11, 69 (2021).","journal-title":"Blood cancer J."},{"key":"50412_CR64","doi-asserted-by":"crossref","unstructured":"Whilding, L. M. & Maher, J. CAR T-cell immunotherapy: The path from the by-road to the freeway? Molecular oncology 9, 1994\u20132018 (2015).","DOI":"10.1016\/j.molonc.2015.10.012"},{"key":"50412_CR65","first-page":"372","volume":"16","author":"NN Shah","year":"2019","unstructured":"Shah, N. N. & Fry, T. J. Mechanisms of resistance to CAR T cell therapy. Nat. reviews Clin. Oncol. 16, 372\u2013385 (2019).","journal-title":"Nat. reviews Clin. Oncol."},{"key":"50412_CR66","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown, C. E. et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N. Engl. J. Med. 375, 2561\u20132569 (2016).","journal-title":"N. Engl. J. Med."},{"key":"50412_CR67","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/2326-6066.CIR-17-0189","volume":"5","author":"J Tchou","year":"2017","unstructured":"Tchou, J. et al. Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer. Cancer Immunol. Res. 5, 1152\u20131161 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"50412_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda, S. M. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat. Reviews Clin. Oncol. 21, 47\u201366 (2024).","journal-title":"Nat. Reviews Clin. Oncol."},{"key":"50412_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","volume":"33","author":"E Lanitis","year":"2015","unstructured":"Lanitis, E., Irving, M. & Coukos, G. Targeting the tumor vasculature to enhance T cell activity. Curr. Opin. Immunol. 33, 55\u201363 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"50412_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2017.00066","volume":"8","author":"LC Dieterich","year":"2017","unstructured":"Dieterich, L. C. et al. Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation. Front. Immunol. 8, 66 (2017).","journal-title":"Front. Immunol."},{"key":"50412_CR71","doi-asserted-by":"publisher","first-page":"1191774","DOI":"10.3389\/fcell.2023.1191774","volume":"11","author":"N Mani","year":"2023","unstructured":"Mani, N., Andrews, D. & Obeng, R. C. Modulation of T cell function and survival by the tumor microenvironment. Front. Cell. Dev. Biology. 11, 1191774 (2023).","journal-title":"Front. Cell. Dev. Biology"},{"key":"50412_CR72","doi-asserted-by":"publisher","first-page":"a041170","DOI":"10.1101\/cshperspect.a041170","volume":"12","author":"P Alcaide","year":"2022","unstructured":"Alcaide, P. & Mechanisms Regulating, T. Cell\u2013Endothelial Cell Interactions. Cold Spring Harbor Perspect. Med. 12, a041170 (2022).","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"50412_CR73","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1128\/jvi.71.12.9323-9332.1997","volume":"71","author":"J Shen","year":"1997","unstructured":"Shen, J., T-To, S. S., Schrieber, L. & King, N. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 71, 9323\u20139332 (1997).","journal-title":"J. Virol."},{"key":"50412_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10238-024-01490-1","volume":"24","author":"D Ribatti","year":"2024","unstructured":"Ribatti, D. The crossroad between tumor and endothelial cells. Clin. Experimental Med. 24, 227 (2024).","journal-title":"Clin. Experimental Med."},{"key":"50412_CR75","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/sj.bjc.6690057","volume":"79","author":"C Liu","year":"1999","unstructured":"Liu, C., Sheen, T., Ko, J. & Shun, C. Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer. Br. J. Cancer. 79, 360\u2013362 (1999).","journal-title":"Br. J. Cancer"},{"key":"50412_CR76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer. 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"50412_CR77","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41423-023-01032-x","volume":"20","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. Cell Mol. Immunol. 20, 739\u2013776 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"50412_CR78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.omto.2019.12.003","volume":"16","author":"EC Eckert","year":"2020","unstructured":"Eckert, E. C. et al. Generation of a tumor-specific chemokine gradient using oncolytic vesicular stomatitis virus encoding CXCL9. Mol. Therapy-Oncolytics. 16, 63\u201374 (2020).","journal-title":"Mol. Therapy-Oncolytics"},{"key":"50412_CR79","doi-asserted-by":"publisher","first-page":"C167","DOI":"10.1152\/ajpcell.00151.2022","volume":"324","author":"D Drouillard","year":"2023","unstructured":"Drouillard, D., Craig, B. T. & Dwinell, M. B. Physiology of chemokines in the cancer microenvironment. Am. J. Physiology-Cell Physiol. 324, C167\u2013C182 (2023).","journal-title":"Am. J. Physiology-Cell Physiol."},{"key":"50412_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-59658-0","volume":"10","author":"MR Nikmaneshi","year":"2020","unstructured":"Nikmaneshi, M. R., Firoozabadi, B., Mozafari, A. & Munn, L. L. A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth. Sci. Rep. 10, 1\u201320 (2020).","journal-title":"Sci. Rep."},{"key":"50412_CR81","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s11538-015-0105-5","volume":"77","author":"M Nikmaneshi","year":"2015","unstructured":"Nikmaneshi, M., Firoozabadi, B. & Saidi, M. Two-Phase acto-cytosolic fluid flow in a moving Keratocyte: a 2D continuum model. Bull. Math. Biol. 77, 1813\u20131832 (2015).","journal-title":"Bull. Math. Biol."},{"key":"50412_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jbiomech.2017.11.025","volume":"67","author":"M Nikmaneshi","year":"2018","unstructured":"Nikmaneshi, M., Firoozabadi, B. & Saidi, M. Fully-coupled mathematical modeling of actomyosin-cytosolic two-phase flow in a highly deformable moving Keratocyte cell. J. Biomech. 67, 37\u201345 (2018).","journal-title":"J. Biomech."},{"key":"50412_CR83","doi-asserted-by":"publisher","first-page":"H2206","DOI":"10.1152\/ajpheart.00348.2009","volume":"297","author":"B Reglin","year":"2009","unstructured":"Reglin, B., Secomb, T. W. & Pries, A. R. Structural adaptation of microvessel diameters in response to metabolic stimuli: where are the oxygen sensors? Am. J. Physiol. Heart Circ. Physiol. 297, H2206\u20132219. https:\/\/doi.org\/10.1152\/ajpheart.00348.2009 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"50412_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1742-7843.2011.00815.x","volume":"110","author":"TW Secomb","year":"2012","unstructured":"Secomb, T. W., Dewhirst, M. W. & Pries, A. R. Structural adaptation of normal and tumour vascular networks. Basic. Clin. Pharmacol. Toxicol. 110, 63\u201369. https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00815.x (2012).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"50412_CR85","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1038\/s41598-024-59296-w","volume":"14","author":"G Gruionu","year":"2024","unstructured":"Gruionu, G. et al. Experimental and theoretical model of microvascular network remodeling and blood flow redistribution following minimally invasive microvessel laser ablation. Sci. Rep. 14, 8767 (2024).","journal-title":"Sci. Rep."},{"key":"50412_CR86","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/427695a","volume":"427","author":"TP Padera","year":"2004","unstructured":"Padera, T. P. et al. Cancer cells compress intratumour vessels. Nature 427, 695\u2013695 (2004).","journal-title":"Nature"},{"key":"50412_CR87","doi-asserted-by":"crossref","unstructured":"Zaman, M. H. et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proceedings of the National Academy of Sciences 103, 10889\u201310894 (2006).","DOI":"10.1073\/pnas.0604460103"},{"key":"50412_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41408-020-00405-z","volume":"11","author":"AK Mishra","year":"2021","unstructured":"Mishra, A. K., Kemler, I. & Dingli, D. Preclinical development of CD126 CAR-T cells with broad antitumor activity. Blood cancer J. 11, 3 (2021).","journal-title":"Blood cancer J."},{"key":"50412_CR89","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41551-021-00779-w","volume":"5","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Control of the activity of CAR-T cells within tumours via focused ultrasound. Nat. biomedical Eng. 5, 1336\u20131347 (2021).","journal-title":"Nat. biomedical Eng."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50412-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:03:55Z","timestamp":1785495835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50412-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.11.17.688869","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"23671"}}